Collaborative influenza vaccine innovation centers (civics) - component c: clinical core (awarded POP: september 16, 2019 - september 15, 2020)

Active Definitive Contract Awarded Last action

Contract number
75N93019C00054
Awardee
Awarding agency
Obligated
$35,619,447

Award facts

Opportunity
Contract value 19% obligated
  • $35,619,447.24 Current, with exercised options
  • $184,406,781.24 Potential, with all options
Completion date 63% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00027 · Civics, component c $0
Funding Only Action P00026 -$950
Other Administrative Action P00025 · EO 14398 - collaborative influenza vaccine innovation centers (civics) - component c: clinical core -$141,187
Exercise an Option P00024 $6,964,479
Supplemental Agreement for work within scope P00023 $257,812
Supplemental Agreement for work within scope P00022 $861,252
Funding Only Action P00021 $806,112
Supplemental Agreement for work within scope P00020 · Component c: clinical core (awarded POP: september 16, 2019 - september 30, 2026) $0
Funding Only Action P00019 -$375,744
Supplemental Agreement for work within scope P00018 $1,720,000
Other Administrative Action P00017 $0
Funding Only Action P00016 -$109,825
Exercise an Option P00015 $781,263
Supplemental Agreement for work within scope P00014 $0
Exercise an Option P00013 $772,503
Supplemental Agreement for work within scope P00012 $0
Other Administrative Action P00011 $0
Exercise an Option P00010 $2,712,270
Exercise an Option P00009 $752,039
Exercise an Option P00008 $1,419,595
Supplemental Agreement for work within scope P00007 $0
Other Administrative Action P00006 · Component c: clinical core (awarded POP: september 16, 2019 - september 15, 2020) $0
Exercise an Option P00005 $738,394
Funding Only Action P00004 $1,315,183
Exercise an Option P00003 $2,352,209
Exercise an Option P00002 $3,829,207
Exercise an Option P00001 $3,070,179
Original award $7,894,656
Show all 28

About this award

The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Duke University for the Collaborative Influenza Vaccine Innovation Centers (CIVICS) Component C Clinical Core on September 16, 2019, with a ceiling value of $184.4 million and ultimate completion date of December 31, 2030.

Work is performed in Durham, NC. The contract is priced on a cost no-fee basis and covers clinical core activities supporting the CIVICS program. No set-aside was used.

Service Contract Inventory reporting shows the contract has scaled substantially since inception. FY2025 labor was 15.5 FTEs with $3.4 million invoiced; FY2024 recorded $5.9 million invoiced across 5.0 FTEs and 10,323 contractor hours. FY2023 peaked at 16.2 FTEs and $4.1 million invoiced (33,669 hours). Derived government-paid hourly rates rose from $79.54/hr in FY2021 to $121.02/hr in FY2023 before increasing sharply to $572.26/hr in FY2024, reflecting shifts in staffing composition or task mix. FY2025 reported no subcontractors; Duke self-performed all labor.

Quick answers

Who was awarded contract 75N93019C00054?

75N93019C00054 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2019.

How much is contract 75N93019C00054 worth?

The government has obligated $35,619,447 on 75N93019C00054. Its potential value, with all options, is $184,406,781.

Was contract 75N93019C00054 competed?

The extent of competition for 75N93019C00054 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award